ATRISORB-D FREEFLOW BIOABSORBABLE GUIDED TISSUE REGENERATION (GTR) BARRIER WITH 4% DOXYCYCLINE

Bone Grafting Material, Synthetic

ATRIX LABORATORIES, INC.

The following data is part of a premarket notification filed by Atrix Laboratories, Inc. with the FDA for Atrisorb-d Freeflow Bioabsorbable Guided Tissue Regeneration (gtr) Barrier With 4% Doxycycline.

Pre-market Notification Details

Device IDK994137
510k NumberK994137
Device Name:ATRISORB-D FREEFLOW BIOABSORBABLE GUIDED TISSUE REGENERATION (GTR) BARRIER WITH 4% DOXYCYCLINE
ClassificationBone Grafting Material, Synthetic
Applicant ATRIX LABORATORIES, INC. 2579 MIDPOINT DR. Fort Collins,  CO  80525 -4417
ContactAmy Taylor
CorrespondentAmy Taylor
ATRIX LABORATORIES, INC. 2579 MIDPOINT DR. Fort Collins,  CO  80525 -4417
Product CodeLYC  
CFR Regulation Number872.3930 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1999-12-07
Decision Date2000-09-13
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.